CITRYLL
Live / Registered — Registered (as of 14 Sept 2021)
What this means for you
Registered since 14 Sept 2021. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79293817
- Registration number
- 6481068
- Mark type
- Stylized text
- Filed
- 21 Jul 2020
- Published for opposition
- 29 Jun 2021
- Registered
- 14 Sept 2021
- Attorney of record
- Bryce J. Maynard
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of cancers, asthma, COPD, lupus, rheumatoid arthritis, vasculitis, idiopathic pulmonary fibrosis, lung disease, colitis and organ damage due to sepsis; antibodies for the treatment of cancers, asthma, COPD, lupus, rheumatoid arthritis, vasculitis, idiopathic pulmonary fibrosis, lung disease, colitis and organ damage due to sepsis; antibodies for the prevention or treatment of autoimmune diseases; small molecules, gene therapies and peptides for the prevention or treatment of cancers, asthma, COPD, lupus, rheumatoid arthritis, vasculitis, idiopathic pulmonary fibrosis, lung disease, colitis and organ damage due to sepsis
Owner
- Citryll BV, NL
- Citryll BV, NL
- Citryll BV, NL
Prosecution history
- 21 Mar 2022 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 02 Mar 2022 — FINAL DISPOSITION NOTICE SENT TO IB
- 01 Mar 2022 — FINAL DISPOSITION PROCESSED
- 14 Dec 2021 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 04 Dec 2021 — NEW REPRESENTATIVE AT IB RECEIVED
- 14 Sept 2021 — REGISTERED-PRINCIPAL REGISTER
- 29 Jun 2021 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 29 Jun 2021 — PUBLISHED FOR OPPOSITION
- 09 Jun 2021 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 27 May 2021 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 26 May 2021 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 26 May 2021 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 26 May 2021 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 20 Dec 2020 — REFUSAL PROCESSED BY IB
- 27 Nov 2020 — NON-FINAL ACTION MAILED - REFUSAL SENT TO IB